Maharashtra reports 9,927 new coronavirus cases, 56 deaths

Mumbai city reported 1,012 new cases taking its tally to 3,35,595, while two deaths took the fatality count to 11,510.

PTI

March 09, 2021 / 09:46 PM IST

PTI

Maharashtra on Tuesday reported 9,927 new COVID-19 cases which took the caseload to 22,38,398, while 56 fatalities pushed up the death count to 52,556, said a health official.

On the other hand, 12,182 patients were discharged from hospitals during the day, taking the tally of recoveries to 20,89,294, he added.

There are 95,322 active cases in the state now. After several days, the number of active cases declined a little. On Monday, there were 97,637 active cases. Pune city reported the highest 1,110 new cases, taking its tally to 1,01,389.

Mumbai city reported 1,012 new cases taking its tally to 3,35,595, while two deaths took the fatality count to 11,510. Mumbai division, which includes surrounding satellite towns, reported 1,940 new cases and 11 deaths. It increased the cumulative infection figure in the region to 7,44,060 and death toll to 19,901.

Nashik division's COVID-19 tally stood at 3,04,620 with a death count of 5,318. The number of cases recorded in the Pune division so far stood at 5,43,514 and deaths at 11,810. Kolhapur division has reported 1,20,513 cases and 4,080 deaths till now, while Aurangabad division's case tally stood at 85,325 and death count at 2,068.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show